Welcome to LookChem.com Sign In|Join Free

CAS

  • or

26788-23-8

Post Buying Request

26788-23-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

26788-23-8 Usage

Description

1,3,5(10)-Estratrien-3,4,17beta-triol 4-methyl ether, also known as a metabolite of 17β-Estradiol, is a white solid with unique chemical properties. It is derived from 17β-Estradiol, a naturally occurring hormone and the primary female sex hormone. This metabolite possesses a distinct chemical structure, which contributes to its various applications across different industries.

Uses

Used in Pharmaceutical Industry:
1,3,5(10)-Estratrien-3,4,17beta-triol 4-methyl ether is used as a pharmaceutical compound for its potential therapeutic applications. As a metabolite of 17β-Estradiol, it may play a role in hormone regulation and could be utilized in the development of treatments for various hormonal imbalances and related conditions.
Used in Research and Development:
In the field of research and development, 1,3,5(10)-Estratrien-3,4,17beta-triol 4-methyl ether serves as a valuable chemical intermediate. It can be used in the synthesis of other compounds, including those with potential applications in medicine, agriculture, and other industries. Its unique chemical properties make it an interesting subject for further study and experimentation.
Used in Analytical Chemistry:
As a metabolite of 17β-Estradiol, 1,3,5(10)-Estratrien-3,4,17beta-triol 4-methyl ether can be used as a reference material or standard in analytical chemistry. It can be employed in the development and validation of analytical methods for the detection and quantification of 17β-Estradiol and its metabolites in various samples, such as biological fluids, environmental samples, and pharmaceutical products.
Used in Environmental Monitoring:
1,3,5(10)-Estratrien-3,4,17beta-triol 4-methyl ether can be used as a tracer or indicator compound in environmental monitoring studies. Given its origin as a metabolite of 17β-Estradiol, it may help researchers understand the fate and transport of hormones and their metabolites in the environment, as well as their potential impacts on ecosystems and human health.

Check Digit Verification of cas no

The CAS Registry Mumber 26788-23-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,7,8 and 8 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 26788-23:
(7*2)+(6*6)+(5*7)+(4*8)+(3*8)+(2*2)+(1*3)=148
148 % 10 = 8
So 26788-23-8 is a valid CAS Registry Number.
InChI:InChI=1/C19H26O3/c1-19-10-9-12-11-5-7-16(20)18(22-2)14(11)4-3-13(12)15(19)6-8-17(19)21/h5,7,12-13,15,17,20-21H,3-4,6,8-10H2,1-2H3/t12-,13-,15+,17+,19+/m1/s1

26788-23-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-METHOXYESTRADIOL

1.2 Other means of identification

Product number -
Other names 4-Methoxyestrone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:26788-23-8 SDS

26788-23-8Relevant articles and documents

Lack of Cell Proliferative and Tumorigenic Effects of 4-Hydroxyestradiol in the Anterior Pituitary of Rats: Role of Ultrarapid O-Methylation Catalyzed by Pituitary Membrane-Bound Catechol-O-Methyltransferase

Wang, Pan,Mills, Laura H.,Song, Ji-Hoon,Yu, Jina,Zhu, Bao-Ting

, p. 1448 - 1462 (2017/07/24)

In animal models, estrogens are complete carcinogens in certain target sites. 4-Hydroxyestradiol (4-OH-E2), an endogenous metabolite of 17β-estradiol (E2), is known to have prominent estrogenic activity plus potential genotoxicity and mutagenicity. We report here our finding that 4-OH-E2 does not induce pituitary tumors in ACI female rats, whereas E2 produces 100% pituitary tumor incidence. To probe the mechanism, we conducted a short-term animal experiment to compare the proliferative effect of 4-OH-E2 in several organs. We found that, whereas 4-OH-E2 had little ability to stimulate pituitary cell proliferation in ovariectomized female rats, it strongly stimulates cell proliferation in certain brain regions of these animals. Further, when we used in vitro cultured rat pituitary tumor cells as models, we found that 4-OH-E2 has similar efficacy as E2 in stimulating cell proliferation, but its potency is approximately 3 orders of magnitude lower than that of E2. Moreover, we found that the pituitary tumor cells have the ability to selectively metabolize 4-OH-E2 (but not E2) with ultrahigh efficiency. Additional analysis revealed that the rat pituitary expresses a membrane-bound catechol-O-methyltransferase that has an ultralow Km value (in nM range) for catechol estrogens. On the basis of these observations, it is concluded that rapid metabolic disposition of 4-OH-E2 through enzymatic O-methylation in rat anterior pituitary cells largely contributes to its apparent lack of cell proliferative and tumorigenic effects in this target site.

Benzotropolone inhibitors of estradiol methylation: Kinetics and in silico modeling studies

Lambert, Joshua D.,Chen, Dapeng,Wang, Ching Y.,Ai, Ni,Sang, Shengmin,Ho, Chi-Tang,Welsh, William J.,Yang, Chung S.

, p. 2501 - 2507 (2007/10/03)

Natural and synthetic benzotropolone compounds were assessed in vitro for their ability to inhibit hydroxyestradiol methylation by catechol-O- methyltransferase (COMT). The compounds were also modeled in silico with a homology model of human COMT. Purpurogallin (1), purpurogallin carboxylic acid (2), and theaflavin-3,3′-digallate (6) were the most potent inhibitors of 2-hydroxy and 4-hydroxyestradiol methylation (IC50 0.22-0.50 μM). Compounds 1 and 6 decreased the Vmax and increased the Km of COMT, indicating a mixed-type inhibition. Compounds 1 and 2 bound to COMT by inserting the six-membered ring of the benzotropolone into the active site. Decreased acidity of the hydroxyl groups on this ring or increased bulkiness reduced potency. Compound 6 bound by inserting the galloyl ester into the active site, which allowed the compound to overcome increased bulkiness and resulted in restored potency. Further studies are needed to determine the impact in vivo of COMT inhibition by these compounds.

Synthesis of 2-Methoxy- and 4-Methoxy-Estrogens with Halogen-Methoxy Exchange Reaction

Numazawa, Mitsuteri,Ogura, Yuko,Kimura, Katsuhiko,Nagaoka, Masao

, p. 3701 - 3715 (2007/10/02)

Synthesis of 2-methoxy- and 4-methoxy-estrone (6) and (9), 2-methoxy- and 4-methoxy-estradiol (15) and (18), and 2-methoxy- and 4-methoxy-estratriol (24) and (27) are described.Catalytic hydrogenation over Pd/C of 2,4-dibromo or 2,4-diiodo estrogens gave regioselectively the corresponding 4-halogeno derivatives in excellent yields.Reaction of 2-iodo or 4-iodo estradiol and 2-iodo or 4-iodo estriol with NaOCH3 in MeOH and dimethylformamide (DMF) in the presence of CuCl2 gave in an excellent yield and in a good yield, while (6) and (9) were also similarly obtained by the reaction with pyridine instead of DMF.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 26788-23-8